Innovation1 Biotech Appoints Frederick E. Pierce, II to its Board of Directors

NEW YORK, Sept. 15, 2022 (GLOBE NEWSWIRE) -- Innovation1 Biotech Inc. (OTCQB: IVBT) (“Innovation1'' or the “Company”), a small molecule drug discovery company focused on the clinical development of modified Schedule 1 molecules of botanical origin, today announced the appointment of Frederick E. Pierce, II, to its Board of Directors.

Here is the original post:
Innovation1 Biotech Appoints Frederick E. Pierce, II to its Board of Directors